This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Woehlck, H. Articles by Kaslow, O. Search for Related Content PubMed PubMed Citation Articles by Woehlck, H. Articles by Kaslow, O. Related Collections Monitoring (Non-cardiac) Pharmacology

---

TECHNOLOGY, COMPUTING, AND SIMULATION

Safe Use of Pulse Oximetry During Verteporphin Therapy

Harvey Woehlck, MD^*, Dave Herrmann, PharmD, and Olga Kaslow, MD^*

Departments of Anesthesiology, *Medical College of Wisconsin; and Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin

Address correspondence and reprint requests to Harvey Woehlck, MD, Department of Anesthesiology, Froedtert Memorial Lutheran Hospital West, 9200 W. Wisconsin Ave., Milwaukee, WI 53226. Address e-mail to hwoehlck{at}mcw.edu

IMPLICATIONS: Pulse oximetry may produce skin damage after the administration of photosensitizing chemotherapeutic drugs. Surgery must often be performed in near darkness during photodynamic therapy. Limiting the duration of pulse oximetry and rotating sites allowed successful use of pulse oximetry in a long anesthetic during which verteporphin was administered.